The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Friedman Paul A since 2015.
This trader's CIK number is 1236927.
At the time of last reporting, Friedman Paul A was the Director of Madrigal Pharmaceuticals, Inc.. (stock ticker symbol MDGL).
Also see all insider trading activities at Madrigal Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | MDGL | 0 | $0 | 206,256 | $74,625,295 | 206,256 | $1,949,116 |
| 2024 | MDGL | 0 | $0 | 100,000 | $24,449,396 | 100,000 | $944,998 |
| 2018 | MDGL | 8,000 | $967,520 | 73,526 | $21,135,783 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | INCY | 0 | $0 | 100,000 | $8,268,765 | 100,000 | $1,831,999 |
| 2017 | INCY | 0 | $0 | 128,507 | $16,452,239 | 100,000 | $1,831,999 |
| 2015 | INCY | 0 | $0 | 643,994 | $66,733,937 | 523,994 | $8,403,940 |
1. Madrigal Pharmaceuticals, Inc. (MDGL)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-13 | MDGL | Option Ex | 129,172 | 9.45 | 1,220,675 |
| 2025-08-12 | MDGL | Sale | 43,605 | 355.37 | 15,495,778 |
| 2025-08-11 | MDGL | Sale | 3,203 | 350.62 | 1,123,023 |
| 2025-08-12 | MDGL | Option Ex | 43,605 | 9.45 | 412,067 |
| 2025-08-11 | MDGL | Option Ex | 3,203 | 9.45 | 30,268 |
| 2025-08-13 | MDGL | Sale | 129,172 | 366.29 | 47,314,411 |
| 2025-07-18 | MDGL | Option Ex | 1,400 | 9.45 | 13,229 |
| 2025-07-18 | MDGL | Sale | 1,400 | 350.03 | 490,043 |
| 2025-07-17 | MDGL | Sale | 2,700 | 350.83 | 947,254 |
| 2025-07-16 | MDGL | Sale | 26,176 | 353.56 | 9,254,786 |
| 2025-07-17 | MDGL | Option Ex | 2,700 | 9.45 | 25,514 |
| 2025-07-16 | MDGL | Option Ex | 26,176 | 9.45 | 247,363 |
| 2024-04-08 | MDGL | Option Ex | 26,270 | 9.45 | 248,251 |
| 2024-04-08 | MDGL | Sale | 26,270 | 245.85 | 6,458,505 |
| 2024-04-04 | MDGL | Sale | 18,710 | 244.68 | 4,578,018 |
| 2024-04-05 | MDGL | Option Ex | 27,613 | 9.45 | 260,942 |
| 2024-04-03 | MDGL | Sale | 27,407 | 244.38 | 6,697,585 |
| 2024-04-04 | MDGL | Option Ex | 18,710 | 9.45 | 176,809 |
| 2024-04-03 | MDGL | Option Ex | 27,407 | 9.45 | 258,996 |
| 2024-04-05 | MDGL | Sale | 27,613 | 243.19 | 6,715,288 |
| 2018-11-20 | MDGL | Buy | 4,000 | 117.88 | 471,520 |
| 2018-11-19 | MDGL | Buy | 4,000 | 124.00 | 496,000 |
| 2018-06-11 | MDGL | Sale | 73,526 | 287.46 | 21,135,783 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-08-02 | INCY | Option Ex | 22,066 | 18.32 | 404,249 |
| 2019-08-02 | INCY | Sale | 22,066 | 84.41 | 1,862,591 |
| 2019-08-06 | INCY | Option Ex | 77,934 | 18.32 | 1,427,750 |
| 2019-08-06 | INCY | Sale | 77,934 | 82.20 | 6,406,174 |
| 2017-11-16 | INCY | Sale | 28,507 | 105.24 | 3,000,076 |
| 2017-03-16 | INCY | Sale | 8,307 | 151.45 | 1,258,095 |
| 2017-03-17 | INCY | Option Ex | 41,693 | 18.32 | 763,815 |
| 2017-03-16 | INCY | Option Ex | 8,307 | 18.32 | 152,184 |
| 2017-03-17 | INCY | Sale | 41,693 | 148.18 | 6,178,068 |
| 2017-02-23 | INCY | Option Ex | 50,000 | 18.32 | 916,000 |
| 2017-02-23 | INCY | Sale | 50,000 | 120.32 | 6,016,000 |
| 2015-11-18 | INCY | Sale | 125,000 | 115.27 | 14,408,750 |
| 2015-11-18 | INCY | Option Ex | 125,000 | 17.79 | 2,223,750 |
| 2015-11-17 | INCY | Sale | 100,000 | 112.20 | 11,220,300 |
| 2015-11-17 | INCY | Option Ex | 100,000 | 17.79 | 1,779,000 |
| 2015-05-27 | INCY | Sale | 69,132 | 107.42 | 7,426,505 |
| 2015-05-26 | INCY | Sale | 127,619 | 107.27 | 13,689,434 |
| 2015-05-27 | INCY | Option Ex | 69,132 | 14.72 | 1,017,623 |
| 2015-05-26 | INCY | Option Ex | 127,619 | 14.72 | 1,878,551 |
| 2015-05-21 | INCY | Option Ex | 22,651 | 14.72 | 333,422 |
| 2015-05-22 | INCY | Option Ex | 79,592 | 14.72 | 1,171,594 |
| 2015-05-21 | INCY | Sale | 22,651 | 108.83 | 2,465,221 |
| 2015-05-22 | INCY | Sale | 79,592 | 108.12 | 8,605,327 |
| 2015-02-13 | INCY | Sale | 120,000 | 74.32 | 8,918,400 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Friedman Paul A (Director of Madrigal Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.